Clinical Trial Update: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients [Phase 4]

View source ↗

Summary

This clinical trial update reports on the effects and safety of oral vancomycin in patients with primary sclerosing cholangitis (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• oral vancomycin (vancomycin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Primary Sclerosing Cholangitis | Phase 4 | Status: UNKNOWN